<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05117307</url>
  </required_header>
  <id_info>
    <org_study_id>TFP vs ESP on C/S</org_study_id>
    <nct_id>NCT05117307</nct_id>
  </id_info>
  <brief_title>Comparison of Transversalis Fascia Plane Block and Erector Spinae Plane Blocks in Cesarean Section</brief_title>
  <official_title>Comparison of Transversalis Fascia Plane Block and Erector Spinae Plane Blocks in Cesarean Section</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Erzurum Regional Training &amp; Research Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Erzurum Regional Training &amp; Research Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Cesarean section is one of the most common major surgical procedures performed worldwide,,&#xD;
      Post-cesarean analgesia should provide adequate pain control while allowing the mother to&#xD;
      remain active to meet the needs of the baby. Insufficient analgesia after cesarean section&#xD;
      may be associated with acute postoperative pain, chronic pain, higher opioid consumption,&#xD;
      delayed functional capacity, and postpartum depression. Techniques such as neuraxial&#xD;
      techniques, oral and intravenous agents, wound infiltration, and behavioral therapy can be&#xD;
      used in the treatment of post-cesarean pain pain. In addition, Transversus abdominis plane&#xD;
      block (TAP), Quadratus Lumborum block (QLB), Erector Spina block (ESP), Transversalis Fascia&#xD;
      plane block (TFP) are used safely under ultrasound guidance. In this study, it was aimed&#xD;
      primarily to examine the effects of TFP and ESP blocks on pain scores, and secondarily to&#xD;
      evaluate analgesic consumption.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">December 1, 2021</start_date>
  <completion_date type="Anticipated">June 1, 2022</completion_date>
  <primary_completion_date type="Anticipated">December 15, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Opioid Consumption</measure>
    <time_frame>Postoperative first 24 hours</time_frame>
    <description>Opioid consumption postroperative period</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Visual Analog Pain Score</measure>
    <time_frame>Postoperative first 24 hours</time_frame>
    <description>Pain will be evaluated with a Visual Analogue Scale (VAS) score of 0-10 (0= no pain and 10= worst imaginable pain)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Pain</condition>
  <condition>Postoperative Pain</condition>
  <arm_group>
    <arm_group_label>Group ESP</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Ultrasound-guided erector spinae plane block with 20 ml %0.25 bupivacaine, per side</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group TFP</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Ultrasound-guided Transversalis Fascia Plane Block block with 20 ml %0.25 bupivacaine, per side</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Bupivacaine 0.25% Injectable Solution</intervention_name>
    <description>Ultrasound-guided block with 20 ml %0.25 bupivacaine, per side</description>
    <arm_group_label>Group ESP</arm_group_label>
    <arm_group_label>Group TFP</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Between 18-50 years&#xD;
&#xD;
          -  Cesarean Section&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Cesarean Section under general anesthesia&#xD;
&#xD;
          -  emergency cases&#xD;
&#xD;
          -  those with a body mass index greater than 35 kg/m2&#xD;
&#xD;
          -  coagulopathy&#xD;
&#xD;
          -  local infection&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Erzurum Regional Training and Research Hospital</name>
      <address>
        <city>Erzurum</city>
        <state>Yakutiye</state>
        <zip>25100</zip>
        <country>Turkey</country>
      </address>
    </facility>
    <contact>
      <last_name>Omer Doymus</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>November 4, 2021</study_first_submitted>
  <study_first_submitted_qc>November 4, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">November 11, 2021</study_first_posted>
  <last_update_submitted>November 11, 2021</last_update_submitted>
  <last_update_submitted_qc>November 11, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 12, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Erzurum Regional Training &amp; Research Hospital</investigator_affiliation>
    <investigator_full_name>Omer Doymus</investigator_full_name>
    <investigator_title>Medical Doctor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bupivacaine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

